SENS-401 + Placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Inner Ear Disease
Conditions
Inner Ear Disease
Trial Timeline
Oct 21, 2016 → Oct 16, 2017
NCT ID
NCT03071003About SENS-401 + Placebo
SENS-401 + Placebo is a phase 1 stage product being developed by Sensorion for Inner Ear Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT03071003. Target conditions include Inner Ear Disease.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03071003 | Phase 1 | Completed |
Competing Products
3 competing products in Inner Ear Disease
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Anakinra 100Mg/0.67Ml Inj Syringe (Period 1) + Placebo injection (Period 1) + Anakinra 100Mg/0.67Ml Inj Syringe (Period 2) + Placebo injection (Period 2) | Swedish Orphan Biovitrum | Phase 2 | 51 |
| gevokizumab | XOMA | Phase 2 | 44 |
| SENS-218 | Sensorion | Phase 1 | 25 |